Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

New Warning for Raptiva (Oct. 2005)

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
553 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on May 7, 2008

Genentech has notified healthcare professionals about serious blood-related disorders and infections that have been associated with the drug Raptiva (efalizumab) used to treat certain patients with plaque psoriasis.

The labeling for Raptiva now warns about immune-mediated hemolytic anemia, which can become apparent several months after starting treatment, and cautions prescribers to discontinue the drug if this occurs. The new labeling also includes expanded warnings about serious infections and thrombocytopenia associated with Raptiva.

Additional Information:

FDA MedWatch Safety Alert 2005 - Raptiva (efalizumab).
http://www.fda.gov/medwatch/safety/2005/safety05.htm#Raptiva

Category:

News & Politics

Tags:

License:

Standard YouTube License

  • likes, 1 dislikes

Link to this comment:

Share to:
see all

All Comments (1)

Sign In or Sign Up now to post a comment!
  • This was just pulled today on April 8th, 2009. You mean they waited from 2005 til now to pull it from the market? That's deep.

Loading...
Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more